| Vincent J. Angotti |
Currently, Vincent J. Angotti is President, Chief Executive Officer & Director at AcelRx Pharmaceuticals, Inc.
In his past career Mr. Angotti was Chief Executive Officer of XenoPort, Inc., Executive Director-Field Operations at Novartis Pharmaceuticals Corp. and Senior Vice President-Sales & Marketing at Reliant Pharmaceuticals LLC.
Mr. Angotti received an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Cornell University. |
| Raffi Asadorian |
Presently, Raffi Asadorian is Chief Financial & Accounting Officer for AcelRx Pharmaceuticals, Inc. Mr. Asadorian is also on the board of Willow Biosciences, Inc.
He previously was Chief Financial Officer for Amyris, Inc., Chief Financial Officer & Senior Vice President at PLIVA dd, Chief Financial Officer for Unilabs SA and Partner-Transaction Services at PricewaterhouseCoopers LLP.
Raffi Asadorian received an undergraduate degree from Xavier University and an MBA from Manchester Metropolitan University. |
| Mark A. Evashenk |
Presently, Mark A. Evashenk is Vice President-Clinical Operations at AcelRx Pharmaceuticals, Inc.
He previously was Director-Clinical Operations at ALZA Corp.
Mr. Evashenk received an undergraduate degree from the University of California, Davis. |
| Pamela Pierce Palmer |
Founder of Omeros Corp. and AcelRx Pharmaceuticals, Inc., Pamela Pierce Palmer currently occupies the position of Director & Chief Medical Officer at AcelRx Pharmaceuticals, Inc. Dr. Palmer is also Professor at The University of California, San Francisco.
In the past she was Director-Advanced Research & Education at UCSF Pain Management Center.
She received a doctorate from Stanford University, a doctorate from Stanford University School of Medicine and an undergraduate degree from the University of Arizona. |
| Badri N. Dasu |
Presently, Badri N. Dasu holds the position of Chief Engineering Officer at AcelRx Pharmaceuticals, Inc. He is also Member of American Institute of Chemical Engineers and Member of American Association of Medical Instrumentation.
In the past he held the position of Director-Process Development at Cygnus, Inc., Vice President-Medical Device Engineering at Anesiva, Inc., Director-Process Development at Metrika, Inc., Vice President-Manufacturing & Device Development at AlgoRx Pharmaceuticals, Inc. and Vice President-Manufacturing & Process Development at Powderject Pharmaceuticals, Inc.
Badri N. Dasu received an undergraduate degree from Mangalore University and a graduate degree from The University of Tulsa. |
| Adrian Adams |
Adrian Adams is a businessperson who has been the head of 13 different companies and currently holds the position of Chairman of Akebia Therapeutics, Inc. and Chairman for AcelRx Pharmaceuticals, Inc.
In his past career he occupied the position of Chairman & Chief Executive Officer for Neurologix, Inc., Chairman, President & Chief Executive Officer of Impel Pharmaceuticals, Inc., Chief Executive Officer at Aralez Pharmaceuticals Plc, Chief Executive Officer & Director at Aralez Pharmaceuticals, Inc. and Chief Executive Officer & Director at POZEN, Inc. (a subsidiary of Aralez Pharmaceuticals, Inc.), President & Chief Executive Officer for Sumitomo Pharma America, Inc., President & Chief Executive Officer for KOS Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Inspire Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Auxilium Pharmaceuticals LLC, President & Chief Executive Officer for Smithkline Beecham Plc, President & Chief Executive Officer for Novartis Pharmaceuticals UK Ltd. and Director-Sales & Marketing for AstraZeneca, Inc.
Mr. Adams received an undergraduate degree from The University of Manchester and an undergraduate degree from the University of Salford. |
| Richard F. Afable |
Richard F. Afable is a businessperson who has been at the head of 6 different companies is on the board of Chapman University, AcelRx Pharmaceuticals, Inc., Providence Little Co. of Mary Medical Institute and OnSite Waste Technologies, Inc. In his past career he held the position of President & Chief Executive Officer at Hoag Hospital Foundation, Chief Executive Officer at Covenant Health Network, President & Chief Executive Officer for St. Joseph Hoag Health, Chief Medical Officer of Catholic Health East, Chairman for California Hospital Association, President & Chief Executive Officer at Hoag Memorial Hospital Presbyterian, Inc., Trustee at Providence St. Joseph Health, Professor at Wake Forest University and Professor at Northwestern University.
Richard F. Afable received a doctorate and an undergraduate degree from Loyola University of Chicago and a graduate degree from the University of Illinois. |
| Mark Allen Wan |
Founder of 5 different companies, including: Odyssey HealthCare, Inc., Epocrates LLC and Perclose, Inc. Mark Allen Wan and presently is Executive Chairman of Athlon Acquisition Corp., President of Acc Holdco LLC, Managing Director at Three Arch Partners (which he founded in 1993), Member of Three Arch Management LP (a subsidiary of Three Arch Partners) and Partner at Causeway Management LLC (which he founded in 2013). Mr. Wan is also Member of Three Arch Management LP and on the board of 13 other companies.
In his past career he held the position of General Partner for Brentwood Associates, Advisor at Fitlab VC, Non-Executive Chairman for QT Vascular Ltd., Managing Member at Three Arch Management IV LLC, Co-Owner at San Francisco Forty Niners Ltd., Director at Perclose, Inc., Director at Odyssey HealthCare, Inc. and Independent Director at Epocrates LLC.
Mr. Wan received an undergraduate degree from Yale University and an MBA from Stanford Graduate School of Business. |
| Jill M. Broadfoot |
Currently, Jill M. Broadfoot holds the position of Chief Financial Officer for aTyr Pharma, Inc. She is also on the board of AcelRx Pharmaceuticals, Inc.
In her past career she held the position of Chief Financial Officer at Emerald Health Pharmaceuticals, Inc., Chief Financial Officer of Emerald Health Bioceuticals, Inc., Chief Financial Officer, Secretary & Senior VP at Vical, Inc., Vice President-Finance & Controller at DJO Global, Inc., Divisional Controller at Medical Imaging Centers of America, Inc., Audit Manager at Ernst & Young LLP and Vice President & Controller of GW Pharmaceuticals Ltd.
Ms. Broadfoot received an undergraduate degree from San Diego State University. |
| Marina S. Bozilenko |
Presently, Marina S. Bozilenko is President, Chief Executive Officer & Director at Biothea Pharma, Inc. Ms. Bozilenko is also on the board of AcelRx Pharmaceuticals, Inc., SynAct Pharma AB and SH Parent, Inc. and Strategic Advisor at William Blair & Co. LLC.
In the past Ms. Bozilenko held the position of Principal at Kidd & Co. LLC, Managing Director at Banc of America Securities LLC, Managing Director at Vector Securities LLC, MD & Senior MD-West Coast Healthcare Investment at Prudential Vector Healthcare Group, Managing Director & Head-West Coast at Vector Securities International, Inc. and Senior Managing Director at Bear, Stearns & Co., Inc.
Ms. Bozilenko received an undergraduate degree and a graduate degree from The University of Chicago. |
| Stephen J. Hoffman |
Steve joined Skyline in May 2007, based in Boston. Prior to joining Skyline, he was a General Partner of TVM Capital. Steve was the founding President, Chief Executive Officer and a Director of Allos Therapeutics (NASDAQ: ALTH), Inc. where he served as Chairman until 2012. He received his PhD from Northwestern University in chemistry and his MD from the University of Colorado. Dr. Hoffman completed a fellowship in clinical oncology and a residency and immunodermatology fellowship in dermatology, all at the University of Colorado. Steve is a director of AcelRx Pharmaceuticals, Inc. (ACRX) and is on the board of many of our private companies, which include Collegium Pharmaceutical, Concert Pharmaceuticals, Inc., Dicerna Pharmaceuticals, Genocea Biosciences, Proteon Therapeutics, Inc., and Sutro Biopharma. Regarding our national pastime, he thinks the designated hitter is an abomination; still, he roots for the Red Sox but his son is a Yankee fan. |
| Howard B. Rosen |
Howard B. Rosen is a businessperson who has been at the helm of 5 different companies is Member of National Academy of Engineering and on the board of 6 other companies.
In his past career Mr. Rosen was Vice President-Commercial Strategy at Gilead Sciences, Inc., Consultant at McKinsey & Co., Inc., Principal at Integral, Inc., Chairman for Alcobra Ltd., President & Chief Executive Officer for Pearl Therapeutics, Inc., President at ALZA Corp. and Director-Corporate Development at GenPharm International LLC.
He received an undergraduate degree from Stanford University, a graduate degree from Massachusetts Institute of Technology and an MBA from Stanford Graduate School of Business. |
